Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT (Tables)

v3.5.0.2
STOCKHOLDERS' DEFICIT (Tables)
 9 Months Ended
Jun. 30, 2016
Stockholders' Equity Note [Abstract]  
Schedule of stock-based compensation expense

Stock-based compensation expense included in the accompanying statements of operations for the three and nine months ended June 30, 2016 and 2015 is as follows:   

 

    For the three months ended
June 30,		  
    2016     2015  
Research     10,400       10,400  
Product Development     15,600       9,200  
Sales and marketing     7,700       9,100  
General and administrative     7,800       13,700  
Total   $ 41,500     $ 42,400  

 

    For the nine months ended
June 30,		  
    2016     2015  
Research     31,200       31,200  
Product Development     32,400       43,200  
Sales and marketing     22,600       72,500  
General and administrative     26,200       57,800  
Total   $ 112,400     $ 204,700  
Schedule of stock option activity

A summary of stock option activity is as follows: 

 

    Number of 
Shares		     Weighted
Average 
Exercise 
Price		  
Outstanding at September 30, 2015     14,230,011     $ 0.75  
Granted     1,650,000       0.0255  
Exercised     -       -  
Forfeited     -       -  
Outstanding at June 30, 2016     15,880,011     $ 0.67  
Schedule of the status of options outstanding

Following is a summary of the status of options outstanding at June 30, 2016:

  

Exercise
Price ($)		     Number
of Shares		     Expiration
Date		     Weighted Average
Exercise Price ($)		  
$ 0.0255       1,650,000       04/2026     $ 0.0255  
  0.055       1,750,000       08/2025       0.055  
  0.04718       8,795,308       12/2022 – 01/2023       0.04718  
  0.25       2,715,109       03/2023 – 01/2025       0.25  
  0.26       425,000       07/2024       0.26  
  3.00       42,670       03/2022       3.00  
  3.60       28,648       08/2016       3.60  
  3.96       32,928       08/2016       3.96  
  9.00       4,525       11/2016       9.00  
  12.00       28,535       03/2019 – 07/2020       12.00  
  14.10       10,000       03/2021       14.10  
  15.30       1,373       09/2018       15.30  
  16.50       262,441       03/2020       16.50  
  17.70       953       08/2016       17.70  
  24.00       4,667       12/2017       24.00  
  26.70       32,297       09/2017       26.70  
  28.80       11,767       04/2018       28.80  
  32.70       83,790       08/2017       32.70  
$ Total       15,880,011       Average     $ 0.67  

 
Schedule of share-based compensation warrants

The warrant activity for the period starting October 1, 2015, through June 30, 2016, is described as follows:

 

    Number of 
Shares		     Weighted
Average 
Exercise Price		  
Outstanding at September 30, 2015     781,524     $ 0.53  
Granted     102,800,000       0.05  
Exercised     -       -  
Expired     (150,003 )     0.54  
Outstanding at June 30, 2016     103,431,521     $ 0.05  

Schedule of the status of warrants outstanding

Following is a summary of the status of warrants outstanding at June 30, 2016:

 

Exercise
Price		     Number
of Shares		     Expiration
Date		     Weighted Average
Exercise Price		  
$ 0.04718       38,152       03/2018     $ 0.04718  
  0.05       42,000,000 (1)     12/31/2020       0.05  
  0.05       800,000 (2)     12/31/2020       0.05  
  0.05       60,000,000 (3)     12/31/2020       0.05  
  0.25       232,200       03/2017 – 07/2017       0.25  
  0.275       324,000       06/2018 – 03/2019       0.275  
  1.00       20,501       12/2016 – 01/2017       1.00  
  9.00       16,668       07/2017       9.00  
  $ Total       103,431,521             $ 0.05  
Schedule of black-scholes option-pricing model assumption inputs

The range of Black-Scholes option-pricing model assumption inputs for the nine months ended June 30, 2016, were as follows:  

   

December 23, 2015

through

June 30,2016

  
Annual dividend yield     -  
Expected life (years)     5.00  
Risk-free interest rate     1.14% ~ 1.74 %
Expected volatility     255.30% ~ 272.56 %